363 related articles for article (PubMed ID: 25365085)
1. An evidence-based approach to laboratory tests in usual care of patients with rheumatoid arthritis.
Pincus T; Gibson KA; Shmerling RH
Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-23-8. PubMed ID: 25365085
[TBL] [Abstract][Full Text] [Related]
2. Laboratory tests to assess patients with rheumatoid arthritis: advantages and limitations.
Pincus T; Sokka T
Rheum Dis Clin North Am; 2009 Nov; 35(4):731-4, vi-vii. PubMed ID: 19962617
[TBL] [Abstract][Full Text] [Related]
3. RAPID3, an index of only 3 patient self-report core data set measures, but not ESR, recognizes incomplete responses to methotrexate in usual care of patients with rheumatoid arthritis.
Pincus T
Bull Hosp Jt Dis (2013); 2013; 71(2):117-20. PubMed ID: 24032610
[TBL] [Abstract][Full Text] [Related]
4. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
5. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.
Salaffi F; Ciapetti A; Gasparini S; Carotti M; Bombardieri S;
Clin Exp Rheumatol; 2012; 30(6):912-21. PubMed ID: 22935335
[TBL] [Abstract][Full Text] [Related]
6. Relative efficiencies of the 7 rheumatoid arthritis Core Data Set measures to distinguish active from control treatments in 9 comparisons from clinical trials of 5 agents.
Pincus T; Richardson B; Strand V; Bergman MJ
Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-47-54. PubMed ID: 25365089
[TBL] [Abstract][Full Text] [Related]
7. Are patient questionnaire scores as "scientific" as laboratory tests for rheumatology clinical care?
Pincus T
Bull NYU Hosp Jt Dis; 2010; 68(2):130-9. PubMed ID: 20632989
[TBL] [Abstract][Full Text] [Related]
8. Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritis.
Bos WH; Bartelds GM; Wolbink GJ; de Koning MH; van de Stadt RJ; van Schaardenburg D; Dijkmans BA; Nurmohamed MT
J Rheumatol; 2008 Oct; 35(10):1972-7. PubMed ID: 18785316
[TBL] [Abstract][Full Text] [Related]
9. Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort.
Shu J; Bykerk VP; Boire G; Haraoui B; Hitchon C; Thorne JC; Tin D; Keystone EC; Pope JE;
J Rheumatol; 2015 Nov; 42(11):2023-8. PubMed ID: 26329342
[TBL] [Abstract][Full Text] [Related]
10. Number of active joints, not diagnosis, is the primary determinant of function and performance in early synovitis.
Gerber LH; Furst G; Yarboro C; el-Gabalawy H
Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S65-70. PubMed ID: 14969053
[TBL] [Abstract][Full Text] [Related]
11. Association of anti-cyclic citrullinated peptide antibodies with clinical and radiological disease severity in rheumatoid arthritis.
Gupta A; Kaushik R; Kaushik RM; Saini M; Kakkar R
Curr Rheumatol Rev; 2014; 10(2):136-43. PubMed ID: 25599684
[TBL] [Abstract][Full Text] [Related]
12. Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
De Rycke L; Verhelst X; Kruithof E; Van den Bosch F; Hoffman IE; Veys EM; De Keyser F
Ann Rheum Dis; 2005 Feb; 64(2):299-302. PubMed ID: 15166003
[TBL] [Abstract][Full Text] [Related]
13. Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity.
Arntz OJ; Pieters BCH; Thurlings RM; Wenink MH; van Lent PLEM; Koenders MI; van den Hoogen FHJ; van der Kraan PM; van de Loo FAJ
Front Immunol; 2018; 9():2388. PubMed ID: 30420853
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other Core Data Set Measures, but Not by the Absence of Rheumatoid Factor, Anticitrullinated Protein Antibodies, or Radiographic Erosions.
Castrejón I; Dougados M; Combe B; Fautrel B; Guillemin F; Pincus T
J Rheumatol; 2016 Jul; 43(7):1285-91. PubMed ID: 27084913
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid Factor, Anti-Cyclic Citrullinated Peptide Antibody, C-Reactive Protein, and Erythrocyte Sedimentation Rate for the Clinical Diagnosis of Rheumatoid Arthritis.
Shen R; Ren X; Jing R; Shen X; Chen J; Ju S; Yang C
Lab Med; 2015; 46(3):226-9. PubMed ID: 26199263
[TBL] [Abstract][Full Text] [Related]
16. Should we redefine treatment targets in rheumatoid arthritis? Low disease activity is sufficiently strict for patients who are anticitrullinated protein antibody-negative.
de Punder YM; Hendrikx J; den Broeder AA; Valls Pascual E; van Riel PL; Fransen J
J Rheumatol; 2013 Aug; 40(8):1268-74. PubMed ID: 23729803
[TBL] [Abstract][Full Text] [Related]
17. Serum matrix metalloproteinase-3 as predictor of joint destruction in rheumatoid arthritis, treated with non-biological disease modifying anti-rheumatic drugs.
Mamehara A; Sugimoto T; Sugiyama D; Morinobu S; Tsuji G; Kawano S; Morinobu A; Kumagai S
Kobe J Med Sci; 2010 Sep; 56(3):E98-107. PubMed ID: 21063156
[TBL] [Abstract][Full Text] [Related]
18. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness.
del Val del Amo N; Ibanez Bosch R; Fito Manteca C; Gutierrez Polo R; Loza Cortina E
Clin Exp Rheumatol; 2006; 24(3):281-6. PubMed ID: 16870095
[TBL] [Abstract][Full Text] [Related]
19. Anticitrullinated protein antibodies and rheumatoid factor fluctuate in early inflammatory arthritis and do not predict clinical outcomes.
Barra L; Bykerk V; Pope JE; Haraoui BP; Hitchon CA; Thorne JC; Keystone EC; Boire G;
J Rheumatol; 2013 Aug; 40(8):1259-67. PubMed ID: 23378461
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis.
Sengul I; Akcay-Yalbuzdag S; Ince B; Goksel-Karatepe A; Kaya T
Int J Rheum Dis; 2015 Jul; 18(6):640-5. PubMed ID: 26013310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
